No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.8x · 10Y median 1.1x · 17th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T13:20:46.217Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Arhaus, Inc. (ARHS) stock was $10.11 as of Oct 5, 2026, 4:00 PM EDT, down 1.27% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +0.9% · 3-year avg +6.5%/yr
Arhaus, Inc. operates as a distinguished lifestyle brand and upscale purveyor within the home furnishings sector.
Specialty Retail · Boston Heights, OH
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 5, 2026
30 days away
EPS Estimate
0.09
Revenue Est.
$369.69M
Last Quarter Results
EPS
$0.28
vs Estimate
$0.16
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ARHS | $1.43B | $10.11 | -1.27% | +0.93% | N/A | N/A | N/A |
| 2LQDT | $1.35B | $43.22 | -0.02% | +56.71% | +14.55% | +15.27% | vs ARHS |
| 3GT | $1.35B | $4.68 | -3.21% | -39.23% | -24.58% | -16.92% | vs ARHS |
| 4LCID | $1.33B | $4.17 | +0.97% | -83.02% | -55.55% | N/A | vs ARHS |
| 5EYE | $1.32B | $16.52 | +0.73% | -42.63% | -21.96% | N/A | vs ARHS |
| 6BJRI | $1.30B | $61.66 | -0.44% | +95.00% | +7.56% | +5.66% | vs ARHS |
TTM
0.83
$384.90M
vs Estimate
$365.66M
Consensus Rating
Based on 13 analysts
Average Price Target
$10.54
+4.2% upside
Low
$9.00
Current
$10.11
High
$13.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.08 | $0.09 | $0.10 | 11 |
| Quarter ending Dec 2026 | $0.14 | $0.15 | $0.17 | 11 |
| Quarter ending Mar 2027 | $0.04 | $0.04 | $0.04 | 4 |
| Quarter ending Jun 2027 | $0.23 | $0.23 | $0.24 | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.49 | $0.53 | $0.55 | 11 |
| FY 2027 | $0.53 | $0.57 | $0.67 | 11 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $365.98M | $369.69M | $373.96M | 9 |
| Quarter ending Dec 2026 | $381.76M | $392.54M | $398.78M | 9 |
| Quarter ending Mar 2027 | $327.24M | $335.73M | $341.07M | 7 |
| Quarter ending Jun 2027 | $396.56M | $406.84M | $413.31M | 4 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $1.45B | $1.46B | $1.47B | 11 |
| FY 2027 | $1.51B | $1.55B | $1.57B | 11 |
